Skip to content
MarketScale
‹ Back to IndustriesSciences

Oscar Martin Interview – AMI Single Serve Tampa – 2026

The single-serve coffee industry is evolving as convenience and sustainability coexist in innovation. The focus is on commercial solutions like compostable and recyclable packaging. Industry experts like Oscar Martin and Daniel Dutesco from TekniPlex provide insights into the sustainable transformation of coffee capsules.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Tekniplex · Coffee Capsule InnovationCompostable Coffee PodsMaterial ScienceRecyclable Packaging
Share

Key takeaways

01

Convenience and sustainability are now parallel priorities in the coffee industry.

02

Material science is critical to maintaining taste and stability in sustainable packaging.

03

Anticipating unmet needs is essential for leading innovation in coffee capsules.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

 
The single-serve coffee industry is at a pivotal moment, where convenience and sustainability are no longer competing priorities but parallel expectations shaping innovation. At gatherings like the AMI Single Serve Coffee Conference in Tampa, the conversation has clearly shifted from abstract goals to tangible, commercially viable solutions—especially in the realm of compostable and recyclable packaging. Yet, as new materials emerge, the industry faces a familiar but critical tension: how to maintain the premium taste and shelf-life stability consumers expect while transitioning to more sustainable formats. This challenge underscores a broader transformation, where material science is becoming just as central to the coffee experience as the beans themselves.

At the same time, evolving labeling standards, certification pathways, and performance requirements are adding layers of complexity that demand faster collaboration and smarter prototyping. Companies that can anticipate unmet needs and move beyond incremental improvements will define the next wave of innovation in this fast-moving market. To better understand how these dynamics are shaping the future of single-serve capsules, we turn to insights from Oscar Martin, Senior Vice President, and Daniel Dutesco, Global Marketing Director and Demand Generation at TekniPlex.

Video TranscriptExpand ↓

Hello, it's end of day one at the AMI Single Serve Coffee Conference in Tampa. Oscar, thank you again for agreeing to present. Pleasure. For coming to Tampa and making time for us. It is. It's end of day one. So, obviously, there was lots of different topics, lots of different conversations today. What trickled to the top for you? What were some of the things that you kept reoccurring in the conversation that you keep hearing over and over? Yeah. Great question, Daniel. There are some key themes around upholstability. Right? There are some new technology providers that are out there that have mere commercial ready solutions that we would like to have some follow-up conversations around. Yeah. Some some discussion around how to effectively and what are the requirements for labeling from a sustainability perspective. Yeah. You know, the shelf life requirements for compostable products, the certifications, where to get those certifications certified at. And so I think there's definitely some follow-up conversations we want to have with some of those technology think some of the challenges for them that came was, you know, what about taste? How does it compostable, does the experience also come through in the end product? So how does with your traditional cups? Absolutely. So second question, you presented today Yes. On the future of kind of how to future proof single serve capsules. Take me through a little bit through the presentation. Oh, We went through the four waves of of, the consumer experience. Okay. And that fourth wave is all about the next generation and how that experience is coming to life. And most importantly, how can Material Science Solutions enable that whole experience, you know, with regard to premium, taste and flavor through shelf life stability, affordability and convenience. Okay. If from all those different things, if there's one thing you would like people to take away from, the different conversations you had with them Oh, yeah. What would it be? It's a very dynamic market. Things are moving at a very fast scale, which is why responding to customer unmet needs is important. Rapid prototyping, proof of concepts, so we can be two steps ahead from a market perspective and not be a fast follower. Yeah. For me, it's, as well if I can, I think everything you put together at the GIC, hearing the people talk, it's again coming back to the offer we're building there is actually very, very exciting and promising? Absolutely. And and having multiple solutions that are ready Yeah. Whether it's molded fiber Yeah. Or whether it's paper, whether it's recyclable plastic solutions with PCR, you have to be ready with alternatives because this market is moving at a phenomenal pace. That's incredible. Alright. Thank you again. Thank you. Thank you. I look forward to the next next time I recruit you into to come to Zen. Alright. Thank you very much. Alright. Take care. Bye bye.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

T
Tekniplex
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

T
Tekniplex
OM
Oscar Martin

Senior Vice President

TekniPlex

DD
Daniel Dutesco

Global Marketing Director and Demand Generation

TekniPlex

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512